COSCIENS Biopharma Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-16.8M | $-25.0M | $-50.1M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $100.0K | $112.0K | $260.0K |
| Amortization | $-38.0K | $-83.0K | — |
| Stock-Based Compensation | $95.0K | $31.0K | $91.0K |
| Net Cash from Operating Activities | $-22.9M | $-29.0M | $-33.8M |
| Investing Activities | |||
| Capital Expenditures | $4.0K | $66.0K | $26.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $307.0K | $-314.0K | $913.0K |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $8.0M | $9.9M | $40.8M |
| Net Change in Cash | $-14.2M | $-19.5M | $6.5M |
| Free Cash Flow | $-22.9M | $-29.1M | $-33.9M |